首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative Bactericidal Activities of Ciprofloxacin Clinafloxacin Grepafloxacin Levofloxacin Moxifloxacin and Trovafloxacin against Streptococcus pneumoniae in a Dynamic In Vitro Model
【2h】

Comparative Bactericidal Activities of Ciprofloxacin Clinafloxacin Grepafloxacin Levofloxacin Moxifloxacin and Trovafloxacin against Streptococcus pneumoniae in a Dynamic In Vitro Model

机译:在动态体外模型中环丙沙星克林沙星格雷帕沙星左氧氟沙星莫西沙星和Trovafloxacin对肺炎链球菌的比较杀菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several new quinolones that exhibit enhanced in vitro activity against Streptococcus pneumoniae have been developed. Using a dynamic in vitro model, we generated time-kill data for ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against three isolates of quinolone-susceptible S. pneumoniae. Three pharmacokinetic profiles were simulated for each of the study agents (0.1, 1, and 10 times the area under the concentration-time curve [AUC]). Target 24-h AUCs were based upon human pharmacokinetic data resulting from the maximal daily doses of each agent. Ciprofloxacin was the least active agent against all three isolates. With regimens that simulated the human 24-h AUC, ciprofloxacin resulted in an initial, modest decline in the numbers of CFU per milliliter; however, by 48 h the numbers of CFU per milliliter returned to or exceeded the starting inoculum. At the AUC, levofloxacin resulted in variable bacteriostatic and bactericidal activities against the isolates. The remaining agents yielded bactericidal (99.9% reduction) activity by 48 h with regimens that simulated the AUC. At 0.1 time the AUC ciprofloxacin and levofloxacin produced no inhibitory effect, grepafloxacin exhibited bacteriostatic activity, trovafloxacin had mixed static and cidal activities, and clinafloxacin and moxifloxacin caused significant reductions in the numbers of CFU per milliliter by 48 h. All six agents produced cidal activity at 10 times the AUC. In this dynamic in vitro model of infection, the quinolones demonstrated various degrees of activity against S. pneumoniae. The rank order of activity, with respect to bactericidal effect, was ciprofloxacin (least active) ≪ levofloxacin < grepafloxacin, trovafloxacin < clinafloxacin and moxifloxacin (most active). The rank order of the agents with respect to the selection of resistance was ciprofloxacin (most likely) > grepafloxacin, moxifloxacin, and trovafloxacin > levofloxacin > clinafloxacin.
机译:已经开发出几种表现出增强的抗肺炎链球菌体外活性的喹诺酮类药物。使用动态体外模型,我们针对三种对喹诺酮敏感的肺炎链球菌分离株产生了环丙沙星,克林沙星,格列沙星,左氧氟沙星,莫西沙星和曲伐沙星的时间杀灭数据。对每种研究药物模拟了三种药代动力学曲线(浓度-时间曲线[AUC]下面积的0.1、1和10倍)。靶向24小时AUC是基于每种药物的最大每日剂量得出的人类药代动力学数据。环丙沙星对三种分离物的活性最低。采用模拟人24小时AUC的方案,环丙沙星导致每毫升CFU数量出现最初的,适度的下降。但是,到48小时时,每毫升CFU的数量又回到或超过了起始接种量。在AUC,左氧氟沙星导致针对分离物的可变抑菌和杀菌活性。其余药物在48小时内产生了模拟AUC的杀菌活性(降低了99.9%)。在0.1倍时,AUC环丙沙星和左氧氟沙星不产生抑制作用,格列沙星显示出抑菌活性,曲伐沙星具有混合的静电和杀灭活性,而克林沙星和莫西沙星在48 h时导致每毫升CFU数量显着降低。所有六种药剂产生的杀灭活性均为AUC的10倍。在这种动态体外感染模型中,喹诺酮类药物对肺炎链球菌具有不同程度的活性。就杀菌效果而言,活性的等级顺序为环丙沙星(最低活性)≪左氧氟沙星<格列沙星,曲伐沙星<克林沙星和莫西沙星(活性最高)。关于抗药性选择的药剂的等级顺序是环丙沙星(最可能)>格列沙星,莫西沙星和曲伐沙星>左氧氟沙星>克林沙星。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号